Teleflex (TFX) Income from Discontinued Operations (2009 - 2026)
Teleflex's (TFX) quarterly Income from Discontinued Operations came in at 673000.0 in Q1 2026, down 90.9% YoY from 7392000.0 in Q1 2025, and up 100.51% on a QoQ basis from 132968000.0 in Q4 2025.
Teleflex (TFX) Income from Discontinued Operations (2009 - 2026) Analysis & Trends
Teleflex (TFX) has 18 years of Income from Discontinued Operations data on file, last reported at 673000.0 in Q1 2026.
- Quarterly Income from Discontinued Operations fell 90.9% year-over-year to 673000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 132300000.0 (down 403.45% YoY) and the FY2025 annual result came in at 133004000.0, down 468.73% from the prior year.
- Income from Discontinued Operations rose to 673000.0 in Q1 2026, from 132968000.0 in the prior quarter.
- In the past five years, Income from Discontinued Operations ranged from a high of 36217000.0 in Q4 2024 to a low of 132968000.0 in Q4 2025.
- A 5-year average of 3412312.5 and a median of 9000.0 in 2022 frame the typical range for Income from Discontinued Operations.
- The widest YoY moves for Income from Discontinued Operations: up 30474.34% in 2023, down 3240.0% in 2023.
- Tracing TFX's Income from Discontinued Operations over 5 years: stood at 113000.0 in 2022, then jumped by 30474.34% to 34549000.0 in 2023, then increased by 4.83% to 36217000.0 in 2024, then slumped by 467.14% to 132968000.0 in 2025, then jumped by 100.51% to 673000.0 in 2026.
- The last three Income from Discontinued Operations figures came in at 673000.0 (Q1 2026), 132968000.0 (Q4 2025), and 5000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Discontinued) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -74.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | - |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | - |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | - |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -9.00 Mn |
| 10 | Teleflex | 6.03 Bn | 5.73 Bn | 331.71 Mn | 60.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.32 Mn |
| Mar 31, 2026 | 673,000.00 |
| Dec 31, 2025 | -132.97 Mn |
| Sep 28, 2025 | -5,000.00 |
| Mar 30, 2025 | 7.39 Mn |
| Dec 31, 2024 | 36.22 Mn |
| Sep 29, 2024 | 26,000.00 |
| Jun 30, 2024 | -37,000.00 |
| Mar 31, 2024 | -135,000.00 |
| Dec 31, 2023 | 34.55 Mn |
| Oct 1, 2023 | -157,000.00 |
| Jul 2, 2023 | -26,000.00 |
| Apr 2, 2023 | -163,000.00 |
| Dec 31, 2022 | 113,000.00 |
| Sep 25, 2022 | 5,000.00 |
| Jun 26, 2022 | -13,000.00 |
| Mar 27, 2022 | -68,000.00 |
| Dec 31, 2021 | 185,000.00 |
| Sep 26, 2021 | -98,000.00 |
| Jun 27, 2021 | -11,000.00 |